Ozempic is not bad for business
Wait for it... we really do not yet know the long-term costs and consequences (health outcomes) of a regime of weight-loss drugs over self discipline. Let's see, we have had thalidomide, LSD, oxycontin, fentanyl... to name just a few drugs that were claimed to have great promise and brought great pain and suffering (and personal and social costs).
You're concerned that people might construe Ozempic as being 'bad for business [across the board]'?
Ie not just that it will create winners and losers, but that it will lead to less 'business' overall. Which in macro terms we might characterise as a drop in aggregate demand?